NYSE:CMN - New York Stock Exchange, Inc. - US1380981084
81.14
+0.62 (+0.77%)
The current stock price of CMN is 81.14 null. In the past month the price increased by 16.97%. In the past year, price increased by 25.06%.
Cantel Medical Corp. is a healthcare company concentrating primarily in infection prevention and control products and diagnostic and therapeutic medical equipment. Through its United States subsidiary, MediVators, Inc., Cantel serves customers worldwide by designing, developing, manufacturing, marketing and distributing innovative products for the infection prevention and control industry.
CANTEL MEDICAL CORP
150 CLOVE ROAD
LITTLE FALLS NJ 07424
CEO: Charles M. Diker
Phone: 973-890-7220
The current stock price of CMN is 81.14 null. The price increased by 0.77% in the last trading session.
The exchange symbol of CANTEL MEDICAL CORP is CMN and it is listed on the New York Stock Exchange, Inc. exchange.
CMN stock is listed on the New York Stock Exchange, Inc. exchange.
CANTEL MEDICAL CORP (CMN) has a market capitalization of 3.38B null. This makes CMN a Mid Cap stock.
CANTEL MEDICAL CORP (CMN) has a support level at 77.51 and a resistance level at 81.87. Check the full technical report for a detailed analysis of CMN support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CANTEL MEDICAL CORP (CMN) has a dividend yield of 0.15%. The yearly dividend amount is currently 0.14. Check the full fundamental report for a detailed analysis of CMN dividend history, reliability and sustainability.
The PE ratio for CANTEL MEDICAL CORP (CMN) is 56.35. This is based on the reported non-GAAP earnings per share of 1.44 and the current share price of 81.14 null. Check the full fundamental report for a full analysis of the valuation metrics for CMN.
ChartMill assigns a technical rating of 9 / 10 to CMN. When comparing the yearly performance of all stocks, CMN is one of the better performing stocks in the market, outperforming 77.67% of all stocks.
Over the last trailing twelve months CMN reported a non-GAAP Earnings per Share(EPS) of 1.44.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 104.9% | ||
ROA | 10.64% | ||
ROE | 16.7% | ||
Debt/Equity | 20.34 |